LIMES Schlosskliniken AG (ETR:LIK)
Germany · Delayed Price · Currency is EUR 520.00
-10.00 (-1.89%)
Sep 16, 2026, 3:18 PM CET
LIMES Schlosskliniken AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 158 | 106 | 97 | 83 | 94 | 60 | |
Market Cap Growth | 40.00% | 9.10% | 16.90% | -11.25% | 55.34% | 101.96% |
Enterprise Value | 160 | 107 | 98 | 85 | 91 | 61 |
Last Close Price | 530.00 | 347.26 | 325.68 | 278.59 | 313.90 | 202.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.91 | 18.65 | 31.28 | 24.52 | 22.32 | 15.31 |
Forward PE | 18.75 | 14.04 | 18.51 | - | - | - |
PS Ratio | 2.78 | 2.12 | 2.60 | 2.24 | 3.26 | 2.58 |
PB Ratio | 6.10 | 3.96 | 4.91 | 5.00 | 8.38 | 9.57 |
P/TBV Ratio | 8.82 | 5.87 | 10.17 | 13.09 | 34.85 | - |
P/FCF Ratio | 23.24 | 93.33 | 39.02 | - | 14.00 | 13.81 |
P/OCF Ratio | 13.08 | 10.87 | 13.04 | 13.23 | 11.67 | 12.65 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.82 | 2.15 | 2.62 | 2.29 | 3.16 | 2.61 |
EV/EBITDA Ratio | 11.82 | 8.41 | 13.93 | 11.09 | 10.52 | 10.18 |
EV/EBIT Ratio | 16.94 | 11.54 | 22.89 | 16.93 | 15.18 | 13.52 |
EV/FCF Ratio | 23.54 | 94.37 | 39.35 | - | 13.59 | 14.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.34 | 0.40 | 0.53 | 0.61 | 0.81 | 0.69 |
Debt / EBITDA Ratio | 0.65 | 0.84 | 1.49 | 1.32 | 1.04 | 0.72 |
Debt / FCF Ratio | 1.29 | 9.43 | 4.20 | - | 1.35 | 0.99 |
Net Debt / Equity Ratio | 0.02 | 0.02 | -0.02 | 0.09 | -0.17 | 0.29 |
Net Debt / EBITDA Ratio | 0.04 | 0.03 | -0.06 | 0.21 | -0.22 | 0.31 |
Net Debt / FCF Ratio | 0.08 | 0.37 | -0.16 | -4.98 | -0.28 | 0.42 |
Asset Turnover | 1.30 | 1.19 | 1.04 | 1.24 | 1.28 | 1.55 |
Inventory Turnover | 249.14 | 330.37 | 250.11 | 254.86 | 320.14 | 1258.70 |
Quick Ratio | 2.93 | 3.96 | 2.90 | 2.97 | 4.33 | 2.63 |
Current Ratio | 3.13 | 4.13 | 3.33 | 3.43 | 4.82 | 3.09 |
Return on Equity (ROE) | 27.67% | 30.16% | 17.70% | 28.08% | 55.57% | 91.41% |
Return on Assets (ROA) | 13.54% | 13.89% | 7.47% | 10.49% | 16.63% | 18.73% |
Return on Invested Capital (ROIC) | 27.12% | 30.93% | 17.78% | 31.14% | 59.58% | 72.01% |
Return on Capital Employed (ROCE) | 25.30% | 23.00% | 13.00% | 17.40% | 25.60% | 27.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.49% | 5.36% | 3.20% | 4.08% | 4.48% | 6.53% |
FCF Yield | 4.30% | 1.07% | 2.56% | -0.38% | 7.14% | 7.24% |
Dividend Yield | 1.89% | 2.88% | - | - | - | - |
Buyback Yield / Dilution | -2.46% | -1.62% | - | - | - | - |
Total Shareholder Return | -0.57% | 1.26% | - | - | - | - |